Download PDF
Planta Med 1990; 56(6): 676
DOI: 10.1055/s-2006-961346
Posters

© Georg Thieme Verlag Stuttgart · New York

Kedarcidin, A New Antitumor Antibiotic: Isolation, Characterization, and Biological Activity

S. J. Hofstead, J. A. Matson
  • Bristol-Myers Squibb Company, Department of Antitumor Chemistry, Pharmaceutical Research and Development Division, 5 Research Parkway, P.O. Box 5100, Wallingford Connecticut 05492, U.S.A.
Further Information

Publication History

Publication Date:
08 January 2007 (online)

Also available at